Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Results from human pharmacokinetic studies support once-daily dosing for MK-991

Oct. 1, 1998

MEN-10700 highly active against pneumococci, gonococci and meningococci

Oct. 1, 1998

Promising new rhinovirus 3C protease inhibitor emerges from Agouron R&D

Oct. 1, 1998

Comparative in vitro antipneumococcal activity of CFC-222 presented at ICAAC

Oct. 1, 1998

ICAAC presentation for potent new anti-HCMV agent from RPR with novel mechanism of action

Oct. 1, 1998

Twice-daily Viracept as safe and effective as the approved t.i.d. schedule

Oct. 1, 1998

Major pediatric study supports safety and efficacy of pneumococcal vaccine

Oct. 1, 1998

Aviron presents new clinical data for FluMist at ICAAC

Oct. 1, 1998

IB-367: preclinical results presented at ICAAC support clinical trials in oral mucositis

Sep. 30, 1998

Potent, broad-spectrum, orally active 2-pyridone antibacterial enters Abbott pipeline

Sep. 30, 1998

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...